Jason Grady

Interim Chief Executive Officer

DSS, Inc.

275 Wiregrass Pkwy, West Henrietta, NY 14586

www.dssworld.com | NYSE American: DSS

DSS focuses on operating business segments in blockchain security, consumer, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. The DSS business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs.

Jason Grady serves as the Interim Chief Executive Officer of DSS, Inc., and concurrently holds the position of President at Premier Packaging Corporation, a wholly owned subsidiary of DSS, Inc. Additionally, Jason is an integral member of the DSS Executive Committee, contributing his expertise in various board and officer roles within the company. These include serving as CEO and Director of DSS Biohealth Holdings, President and COO of DSS Financial Management, COO & Director of HWH World, COO and Director of USX Securities, and Chief Business Officer of Impact Bio Medical, among others. With over 25 years of experience navigating the forefront of business growth and industry dominance, Jason has played a pivotal role in propelling DSS into the successful, global portfolio company it is today.

Heather Fritzsche

heatherf@spearheadglobal.com

Heather Fritzsche is the co-founder of Spearhead Global, an innovative packaging solutions provider. Included on the Inc 5000 list, Spearhead Global now operates in the United States, Mexico, Italy, and India.

With a career spanning over two decades, Heather has been instrumental in redefining the spirits industry, working with iconic brands to create award-winning packaging that stands out on shelves and elevates the customer experience. As the owner of a certified Women’s Business Enterprise, Heather is known for disrupting the industry with revolutionary ideas that challenge the status quo.

Website: www.kleinerlabs.com

Dr. Kleiner is a Denver, CO native who trained at Stanford University, University of Colorado, Rush/Presbyterian-St. Luke’s Hospital in Chicago and University of CA at San Diego for pre-medical, medical and residency training. He was an NIH postdoctoral fellow in the biochemistry of tendons and ligaments and fellowship trained in adult and pediatric reconstructive spinal surgery at Colorado Spine Center and the University of Colorado. He is renowned for his compassion, medical knowledge, skill as a surgeon, and as a teacher and scholar.

Dr. Kleiner is a devotee of minimally invasive strategies for spinal surgery and has contributed to the armamentarium of instrumentation, strategies and intellectual property in this area with over 60 issued patents. He is the founder and CEO of Kleiner Device Labs (KDL) and an Assistant Clinical Professor at The University of Colorado Health Sciences Center. He has concentrated his efforts on commercializing the intellectual property portfolio of KDL and has succeeded in procuring FDA clearance, market acceptance, and sales of two spinal surgical devices designed to improve patient outcomes, simplify complex surgeries, reduce the risk of complications, and make good surgeons better.